202271-32-7Relevant academic research and scientific papers
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
-
Page/Page column 43, (2015/12/18)
A pharmaceutical formulation comprising the compound of formula
Anilinoquinazolines as protein tyrosine kinase inhibitors
-
Page/Page column 80, (2008/06/13)
Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.
Anilinoquinazaolines as protein tyrosine kianse inhibitors
-
Page/Page column 49, (2008/06/13)
Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.
